Companies debate cell line R&D needs
01 August, 2002 by Melissa TrudingerExecutives of three leading stem cell research companies - Stem Cell Sciences CEO Peter Mountford, ES Cell International (ESI) CEO Robert Klupacs and BresaGen medical director Chris Juttner - have debated the need for new human embryonic stem cell lines and the availability of commercially owned cell lines for basic research.
Diversity will be key to Centre of Excellence success: DeVore
31 July, 2002 by Melissa TrudingerMulti-disciplinary research will be crucial to the success of the Centre for Stem Cell and Tissue Repair, its new chief operating officer told a Melbourne stem cell conference yesterday.
Controversies dissuade stem cell researchers, says NIH director
31 July, 2002 by Melissa TrudingerThe deputy director for extramural research at the US National Institutes of Health (NIH) warned delegates at a stem cell conference in Melbourne yesterday that the high level of attention being paid to the controversial research was making it difficult to attract scientists to work in the field.
NHMRC readies itself for new stem cell laws
31 July, 2002 by Melissa TrudingerNational Health and Medical Research Council CEO Prof Alan Pettigrew told a stem cell conference in Melbourne yesterday that the council was already preparing to implement a new embryonic stem cell research and cloning Bill.
Ethics conference hears of therapeutic cloning doubts
29 July, 2002 by Melissa TrudingerStem cell researcher Prof Alan Trounson would support a moratorium on therapeutic cloning, but says that research into embryonic stem cells is still necessary.
Stem Cells Centre of Excellence to set IP rules
19 July, 2002 by Tanya HollisA series of meetings will take place this month to set the intellectual property ground rules for the new Centre for Stem Cells and Tissue Repair.
Cellular processing
12 July, 2002 by Ben WorthenThe latest computer to come out of the University of Southern California isn't newsworthy for its small size or computational power. It's notable because it is made from DNA, the microscopic acids that reside in every cell and are responsible for all life.
Lawyers suggest patent system could be used as ethics tool
08 July, 2002 by Iain ScottEthical concerns over issues like the use of embryonic stem cells in research could be addressed in the patent system, a new paper has argued.
Singapore could allow therapeutic cloning for stem cell research
08 July, 2002 by Tanya HollisA Singapore government ethics committee has recommended in favour of therapeutic cloning in a move that could prove to be a research boon for private Australian company ES Cell International (ESI).
How Stem Cell Sciences tapped Japan's biobusiness bid
01 July, 2002 by Tanya HollisThe foundations for Japan's first stem cell company were laid in 1994 when two scientists from different countries met at an institute tens of thousands of kilometres from their respective homes.
Alzheimer's researcher wins Mayne Florey Medal
27 June, 2002 by Melissa TrudingerThe Australian Institute of Political Science has presented Prof Colin Masters with the 2002 Mayne Florey Medal, recognising his world-leading research into the cause of Alzheimer's disease and other brain diseases of the elderly.
We won't use ES cells: med institute
25 June, 2002 by Tanya HollisA children's research institute with a strong focus on gene therapy and stem cell work has declared it does not support human embryonic stem cell research.
Capillary Electrophoresis: complex technology for complex science
24 June, 2002 by Melissa TrudingerCapillary electrophoresis (CE) is a technique that allows researchers to separate analytes based on their differential mobilities in aqueous media when an electric field is applied.
Adult stem cell research adds fuel to local debate
21 June, 2002 by Tanya HollisNew research suggesting adult stem cells could be as flexible as embryonic stem cells has re-ignited debate over whether controversial Australian laws to permit research on human embryos should go ahead.
SCS establishes Japan's first stem cell company
20 June, 2002 by Tanya HollisMelbourne's Stem Cell Sciences (SCS) has added another block to its global network with the establishment of Japan's first stem cell company.
